Literature DB >> 13673093

Combined drug treatment of tuberculosis. III. Clinical application of the principles of appropriate and adequate chemotherapy to the treatment of pulmonary tuberculosis.

W F RUSSELL, I KASS, A D HEATON, S H DRESSLER, G MIDDLEBROOK.   

Abstract

Entities:  

Keywords:  TUBERCULOSIS, PULMONARY/therapy

Mesh：

Year:  1959        PMID： 13673093      PMCID： PMC442091          DOI： 10.1172/JCI103912

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  18 in total

1.  The role of biotin and carbon dioxide in the cultivation of Mycobacterium tuberculosis.

Authors:  W B SCHAEFER; M L COHN; G MIDDLEBROOK
Journal:  J Bacteriol       Date:  1955-06       Impact factor: 3.490

2.  Changing concepts in the treatment of pulmonary tuberculosis.

Authors:  I KASS; W F RUSSELL; A HEATON; T MIYAMOTO; G MIDDLEBROOK; S H DRESSLER
Journal:  Ann Intern Med       Date:  1957-10       Impact factor: 25.391

3.  Sputkm conversion and the metabolism of isoniazid.

Authors:  J CROFTON
Journal:  Am Rev Tuberc       Date:  1958-05

4.  Bacteriology of tuberculosis: laboratory methods.

Authors:  G MIDDLEBROOK; M L COHN
Journal:  Am J Public Health Nations Health       Date:  1958-07

5.  Open healing of tuberculous cavities; results in 40 patients treated conservatively.

Authors:  T M WILSON; L DOYLE; M P GARDINER
Journal:  Br Med J       Date:  1958-07-12

6.  Prognosis of persistent cavitation in sputum-negative cases of tuberculosis following long-term chemotherapy.

Authors:  J B RYDER
Journal:  Tubercle       Date:  1958-04

7.  Hospital treatment of pulmonary tuberculosis; a follow-up study of patients admitted to Edinburgh hospitals in 1953.

Authors:  J D ROSS; N W HORNE; I W GRANT; J W CROFTON
Journal:  Br Med J       Date:  1958-02-01

8.  Effect of para-aminosalicylic acid on serum isoniazid levels in man.

Authors:  W MANDEL; M L COHN; W F RUSSELL; G MIDDLEBROOK
Journal:  Proc Soc Exp Biol Med       Date:  1956-03

9.  Serum isoniazid levels and catalase activities of tubercle bacilli from isoniazid-treated patients.

Authors:  M L COHN; W MANDEL; G MIDDLEBROOK; W F RUSSELL
Journal:  Am J Med Sci       Date:  1957-01       Impact factor: 2.378

10.  Virulence of tubercle bacilli recovered from patients treated with isoniazid.

Authors:  S M STEWART
Journal:  Am Rev Tuberc       Date:  1954-04
View more
  5 in total

1.  Combined drug treatment of tuberculosis. IV. Bacteriologic studies on the sputum and resected pulmonary lesions of tuberculous patients.

Authors:  A D HEATON; W F RUSSELL; J DENST; G MIDDLEBROOK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  The realized and unrealized benefits from chemotherapy for Tuberculosis.

Authors:  T Moulding
Journal:  Public Health Rep       Date:  1967-09       Impact factor: 2.792

3.  New responsibilities for health departments and public health nurses in tuberculosis-- keeping the outpatient on therapy.

Authors:  T Moulding
Journal:  Am J Public Health Nations Health       Date:  1966-03

4.  Antimicrobial therapy of pulmonary tuberculosis.

Authors:  W McDermott
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

5.  The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid.

Authors:  P R Donald; D P Parkin; H I Seifart; H S Schaaf; P D van Helden; C J Werely; F A Sirgel; A Venter; J S Maritz
Journal:  Eur J Clin Pharmacol       Date:  2007-05-16       Impact factor: 3.064
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.